Biotechnology Research Reports

    Next-Generation Sequencing Services Industry Overview   The global  next-generation sequencing services market  size is expected to reach USD 4.55 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 18.3% from 2022 to 2030. The development of next-generation sequencing (NGS) technologies has revolutionized gene sequencing in terms of reproducibility and cost savings. This has resulted in the introduction of several advancements in NGS technology to promote its usage in clinical labs and hospitals. Most current innovations in this field revolve around simplifying the usage of seq-technology and making it more sophisticated. These factors have driven the uptake of NGS services across various end-users.   Next-Generation Sequencing Services Market Segmentation Grand View Research has segmented the global next-generation sequencing services market report on the basis of service type, workflow, end-use, and region:   Based on the

    Gene Therapy Industry Overview   The global gene therapy market size was valued at USD 2.26 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 20-.4% from 2021 to 2028.   The expanding arena of advanced therapies and gene delivery technologies has created an increasingly competitive dynamic where a substantial number of market players are engaged in the commercialization of their gene therapy products. Therapy developers are investing in collaboration/mergers and acquisition deals as a viable strategy to enhance in-house expertise and strengthen product pipelines. These factors are expected to boost the market growth. Although the high prices of currently available therapies incentivize therapy development, it limits accessibility and can result in market withdrawals due to the lack of economic viability of the products.   Gather more insights about the market drivers, restrains and growth of the   Global Gene Therapy Market   Thus, several payment m

    Immunohistochemistry Industry Overview   The global immunohistochemistry market size was valued at USD 1.89 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.4% from 2022 to 2030.   Increasing implementation of automation and machine learning in IHC, coupled with the introduction of technologically advanced Immunohistochemistry (IHC) solutions, is expected to significantly drive the market over the forecast period. Advancements in IHC protocols have boosted its demand to a significant level in disease diagnosis. In addition, the rise in product approvals and the launch of technologically advanced IHC systems for disease diagnosis are further propelling the market growth.   Gather more insights about the market drivers, restrains and growth of the   Global Immunohistochemistry Market   For instance, in August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Companies c

    Primary Cell Culture Industry Overview   The global primary cell culture market size was valued at USD 3.4 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 11.6% from 2021 to 2028.   The market growth can be primarily attributed to the increasing prevalence of chronic conditions, such as cancer, infections, autoimmune diseases, diabetes mellitus, cardiovascular diseases, and nephrological diseases. This has led to an increase in research, facilitating the high adoption of primary cell cultures.   According to the American Cancer Society, there are an estimated 16.9 million cancer patients/survivors in 2020. According to the WHO (2020), 71.0 million people worldwide are suffering from chronic hepatitis C infection. Hence, the rising number of chronic disorders being diagnosed is driving the demand for research on advanced therapies, which is expected to boost the market growth in the coming years.   Gather more insights about the market drivers, r

    Immunoassay Industry Overview   The global immunoassay market size was valued at USD 28.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.2% from 2022 to 2030.   The market growth can be attributed to the increase in chronic and infectious diseases, including the outbreak of COVID-19. In addition, the rise in the geriatric population, which is more prone to chronic and infectious diseases, will aid growth. An increase in the prevalence of chronic conditions, such as cancer, infections, cardiovascular diseases, autoimmune diseases, diabetes mellitus, and nephrological diseases, has led to the wide usage of immunoassay techniques in disease diagnostics. The incidence of cancer is increasing steadily, which is expected to drive the demand for effective diagnostic methods such as immunoassay. This technique is significant in the determination of oncogenesis and diagnosis of cancer, such as benign or malignant, and its different stages. It facilita